Targeting glycogen synthase kinase-3β for therapeutic benefit against oxidative stress in alzheimer's disease: Involvement of the Nrf2-ARE pathway

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Kanninen, Katja ^a,b   White, Anthony R ^b   Koistinaho, Jari ^a,c   Malm, Tarja ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DISULFIRAM; DITHIOCARBAMIC ACID DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3BETA; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PYRROLIDINE DITHIOCARBAMATE; SUPEROXIDE DISMUTASE; TAU PROTEIN; TRANSCRIPTION FACTOR NRF2;

ALCOHOLISM; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; BLOOD BRAIN BARRIER; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME DEGRADATION; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MICROARRAY ANALYSIS; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW;

EID: 79959241490     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/985085     Document Type: Review

References (112)

1. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis Science 1992 256 5054 184 185
2. Crouch P. J., Harding S. M. E., White A. R., Camakaris J., Bush A. I., Masters C. L., Mechanisms of A mediated neurodegeneration in Alzheimer's disease International Journal of Biochemistry and Cell Biology 2008 40 2 181 198 (Pubitemid 350137874)
3. Selkoe D. J., Alzheimer's disease: genes, proteins, and therapy Physiological Reviews 2001 81 2 741 766 (Pubitemid 32267077)
4. Zhu X., Su B., Wang X., Smith M. A., Perry G., Causes of oxidative stress in Alzheimer disease Cellular and Molecular Life Sciences 2007 64 17 2202 2210 (Pubitemid 47347959)
5. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B., Smith M. A., Oxidative damage is the earliest event in Alzheimer disease Journal of Neuropathology and Experimental Neurology 2001 60 8 759 767 (Pubitemid 32678256)
6. Barnham K. J., Masters C. L., Bush A. I., Neurodegenerative diseases and oxidatives stress Nature Reviews Drug Discovery 2004 3 3 205 214 (Pubitemid 38379987)
7. Pratic D., Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows Annals of the New York Academy of Sciences 2008 1147 70 78
8. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease International Journal of Biochemistry and Cell Biology 2007 39 1 44 84 (Pubitemid 44566469)
9. Castegna A., Aksenov M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R., Butterfield D. A., Proteomic identification of oxidatively modified proteins in Alzheimer's disease brainpart II: dihydropyrimidinase-related protein 2, -enolase and heat shock cognate 71 Journal of Neurochemistry 2002 82 6 1524 1532
10. Korolainen M. A., Goldsteins G., Alafuzoff I., Koistinaho J., Pirttil T., Proteomic analysis of protein oxidation in Alzheimer's disease brain Electrophoresis 2002 23 19 3428 3433 (Pubitemid 35230228)
11. Reed T. T., Pierce W. M., Markesbery W. R., Butterfield D. A., Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD Brain Research 2009 1274 C 66 76
12. Subbarao K. V., Richardson J. S., Ang L. S., Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro Journal of Neurochemistry 1990 55 1 342 345
13. Olcese J. M., Cao C., Mori T., Mamcarz M. B., Maxwell A., Runfeldt M. J., Wang LI., Zhang C., Lin X., Zhang G., Arendash G. W., Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease Journal of Pineal Research 2009 47 1 82 96
14. Grimes C. A., Jope R. S., The multifaceted roles of glycogen synthase kinase 3 in cellular signaling Progress in Neurobiology 2001 65 4 391 426 (Pubitemid 32781670)
15. Woodgett J. R., Molecular cloning and expression of glycogen synthase kinase-3/factor A EMBO Journal 1990 9 8 2431 2438
16. Hooper C., Killick R., Lovestone S., The GSK3 hypothesis of Alzheimer's disease Journal of Neurochemistry 2008 104 6 1433 1439 (Pubitemid 351316776)
17. Hu S., Begum A. N., Jones M. R., Oh M. S., Beech W. K., Beech B. H., Yang F., Chen P., Ubeda O. J., Kim P. C., Davies P., Ma Q., Cole G. M., Frautschy S. A., GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals Neurobiology of Disease 2009 33 2 193 206
18. Leroy K., Yilmaz Z., Brion J. P., Increased level of active GSK-3 in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration Neuropathology and Applied Neurobiology 2007 33 1 43 55 (Pubitemid 46090309)
19. Pei J. J., Tanaka T., Tung Y. C., Braak E., Iqbal K., Grundke-Iqbal I., Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain Journal of Neuropathology and Experimental Neurology 1997 56 1 70 78 (Pubitemid 127470328)
20. Plattner F., Angelo M., Giese K. P., The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation Journal of Biological Chemistry 2006 281 35 25457 25465 (Pubitemid 44401934)
21. Pei J. J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., Cowburn R. F., Distribution of active glycogen synthase kinase 3 (GSK-3 ) in brains staged for Alzheimer disease neurofibrillary changes Journal of Neuropathology and Experimental Neurology 1999 58 9 1010 1019 (Pubitemid 29441929)
22. Lucas J. J., Hernndez F., Gmez-Ramos P., Morn M. A., Hen R., Avila J., Decreased nuclear -catenin, tau hyperphosphorylation and neurodegeneration in GSK-3 conditional transgenic mice EMBO Journal 2001 20 1-2 27 39 (Pubitemid 32099099)
23. Hoshi M., Takashima A., Noguchi K., Murayama M., Sato M., Kondo S., Saitoh Y., Ishiguro K., Hoshino T., Imahori K., Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3 in brain Proceedings of the National Academy of Sciences of the United States of America 1996 93 7 2719 2723 (Pubitemid 26114315)
24. Phiel C. J., Wilson C. A., Lee V. M.-Y., Klein P. S., GSK-3 regulates production of Alzheimer's disease amyloid- peptides Nature 2003 423 6938 435 439 (Pubitemid 36626994)
25. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., Imahori K., Exposure of rat hippocampal neurons to amyloid peptide (2535) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 Neuroscience Letters 1996 203 1 33 36
26. Baki L., Neve R. L., Shao Z., Shioi J., Georgakopoulos A., Robakis N. K., Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signaling Journal of Neuroscience 2008 28 2 483 490
27. Peineau S., Taghibiglou C., Bradley C., Wong T. P., Liu L., Lu J., Lo E., Wu D., Saule E., Bouschet T., Matthews P., Isaac J. T. R., Bortolotto Z., Wang Y. T., Collingridge G. L., LTP inhibits LTD in the hippocampus via regulation of GSK3 Neuron 2007 53 5 703 717 (Pubitemid 46283369)
28. Aplin A. E., Gibb G. M., Jacobsen J. S., Gallo J. M., Anderton B. H., In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3 Journal of Neurochemistry 1996 67 2 699 707 (Pubitemid 26255667)
29. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., Nihonmatsu N., Mercken M., Yamaguchi H., Sugihara S., Wolozin B., Presenilin 1 associates with glycogen synthase kinase-3 and its substrate tau Proceedings of the National Academy of Sciences of the United States of America 1998 95 16 9637 9641 (Pubitemid 28506284)
30. Weihl C. C., Ghadge G. D., Kennedy S. G., Hay N., Miller R. J., Roos R. P., Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB Journal of Neuroscience 1999 19 13 5360 5369 (Pubitemid 29300202)
31. Engel T., Hernndez F., Avila J., Lucas J. J., Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3 Journal of Neuroscience 2006 26 19 5083 5090 (Pubitemid 44315289)
32. Hernndez F., Borrell J., Guaza C., Avila J., Lucas J. J., Spatial learning deficit in transgenic mice that conditionally over-express GSK-3 in the brain but do not form tau filaments Journal of Neurochemistry 2002 83 6 1529 1533 (Pubitemid 35477491)
33. Ma Q.-L., Lim G. P., Harris-White M. E., Yang F., Ambegaokar S. S., Ubeda O. J., Glabe C. G., Teter B., Frautschy S. A., Cole G. M., Antibodies against -amyloid reduce A oligomers, glycogen synthase kinase-3 activation and phosphorylation in vivo and in vitro Journal of Neuroscience Research 2006 83 3 374 384 (Pubitemid 43184401)
34. Turenne G. A., Price B. D., Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity BMC Cell Biology 2001 2 1, article 12 12
35. Jope R. S., Johnson G. V. W., The glamour and gloom of glycogen synthase kinase-3 Trends in Biochemical Sciences 2004 29 2 95 102 (Pubitemid 38186580)
36. Bijur G. N., Jope R. S., Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3 in the regulation of HSF-1 activity Journal of Neurochemistry 2000 75 6 2401 2408
37. He B., Meng Y.-H., Mivechi N. F., Glycogen synthase kinase 3 and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock Molecular and Cellular Biology 1998 18 11 6624 6633 (Pubitemid 28500551)
38. Bullock B. P., Habener J. F., Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge Biochemistry 1998 37 11 3795 3809 (Pubitemid 28162935)
39. Jean D., Harbison M., McConkey D. J., Ronai Z., Bar-Eli M., CREB and its associated proteins act as survival factors for human melanoma cells Journal of Biological Chemistry 1998 273 38 24884 24890 (Pubitemid 28454995)
40. Struthers R. S., Vale W. W., Arias C., Sawchenko P. E., Montminy M. R., Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant Nature 1991 350 6319 622 624 (Pubitemid 21912285)
41. Grimes C. A., Jope R. S., Creb DNA binding activity is inhibited by glycogen synthase kinase-3 and facilitated by lithium Journal of Neurochemistry 2001 78 6 1219 1232 (Pubitemid 32899754)
42. Lee K. Y., Koh S. H., Noh M. Y., Park K. W., Lee Y. J., Kim S. H., Glycogen synthase kinase-3 activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells Brain Research 2007 1129 1 89 99 (Pubitemid 46048775)
43. Schfer M., Goodenough S., Moosmann B., Behl C., Inhibition of glycogen synthase kinase 3 is involved in the resistance to oxidative stress in neuronal HT22 cells Brain Research 2004 1005 1-2 84 89 (Pubitemid 38388403)
44. Kaspar J. W., Niture S. K., Jaiswal A. K., Nrf2:INrf2 (Keap1) signaling in oxidative stress Free Radical Biology and Medicine 2009 47 9 1304 1309
45. Chan J. Y., Han X. L., Kan Y. W., Isolation of cDNA encoding the human NF-E2 protein Proceedings of the National Academy of Sciences of the United States of America 1993 90 23 11366 11370 (Pubitemid 23354430)
46. Moi P., Chan K., Asunis I., Cao A., Kan Y. W., Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the -globin locus control region Proceedings of the National Academy of Sciences of the United States of America 1994 91 21 9926 9930 (Pubitemid 24311921)
47. Kensler T. W., Wakabayashi N., Biswal S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annual Review of Pharmacology and Toxicology 2007 47 89 116
48. Lee J. M., Calkins M. J., Chan K., Kan Y. W., Johnson J. A., Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis Journal of Biological Chemistry 2003 278 14 12029 12038 (Pubitemid 36800179)
49. Lee J. M., Shih A. Y., Murphy T. H., Johnson J. A., NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons Journal of Biological Chemistry 2003 278 39 37948 37956 (Pubitemid 37175325)
50. Li J., Lee J. M., Johnson J. A., Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells Journal of Biological Chemistry 2002 277 1 388 394 (Pubitemid 34952070)
51. Inamdar N. M., Ahn Y. I., Alam J., The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors Biochemical and Biophysical Research Communications 1996 221 3 570 576 (Pubitemid 26153905)
52. Li Y., Jaiswal A. K., Regulation of human NAD(P)H: quinone oxidoreductase gene: role of AP1 binding site contained within human antioxidant response element Journal of Biological Chemistry 1992 267 21 15097 15104
53. Mulcahy R. T., Wartman M. A., Bailey H. H., Gipp J. J., Constitutive and -naphthoflavone-induced expression of the human -glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence Journal of Biological Chemistry 1997 272 11 7445 7454 (Pubitemid 27166457)
54. Nguyen T., Nioi P., Pickett C. B., The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress Journal of Biological Chemistry 2009 284 20 13291 13295
55. Rushmore T. H., Morton M. R., Pickett C. B., The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity Journal of Biological Chemistry 1991 266 18 11632 11639 (Pubitemid 21906996)
56. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J. D., Yamamoto M., Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes and Development 1999 13 1 76 86 (Pubitemid 29045117)
57. Eggler A. L., Liu G., Pezzuto J. M., Van Breemen R. B., Mesecar A. D., Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2 Proceedings of the National Academy of Sciences of the United States of America 2005 102 29 10070 10075 (Pubitemid 41023327)
58. Kobayashi M., Yamamoto M., Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species Advances in Enzyme Regulation 2006 46 1 113 140 (Pubitemid 44301353)
59. Tong K. I., Kobayashi A., Katsuoka F., Yamamoto M., Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism Biological Chemistry 2006 387 10-11 1311 1320 (Pubitemid 44691409)
60. Cullinan S. B., Gordan J. D., Jin J., Harper J. W., Diehl J. A., The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase Molecular and Cellular Biology 2004 24 19 8477 8486 (Pubitemid 39245070)
61. Kobayashi A., Kang M. I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Molecular and Cellular Biology 2004 24 16 7130 7139 (Pubitemid 39014439)
62. Sekhar K. R., Yan X. X., Freeman M. L., Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2 Oncogene 2002 21 44 6829 6834 (Pubitemid 35221925)
63. Stewart D., Killeen E., Naquin R., Alam S., Alam J., Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium Journal of Biological Chemistry 2003 278 4 2396 2402 (Pubitemid 36801313)
64. Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11908 11913 (Pubitemid 34994497)
65. Kobayashi M., Li L., Iwamoto N., Nakajima-Takagi Y., Kaneko H., Nakayama Y., Eguchi M., Wada Y., Kumagai Y., Yamamoto M., The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds Molecular and Cellular Biology 2009 29 2 493 502
66. de Vries H. E., Witte M., Hondius D., Rozemuller A. J. M., Drukarch B., Hoozemans J., van Horssen J., Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radical Biology and Medicine 2008 45 10 1375 1383
67. Tanaka N., Ikeda Y., Ohta Y., Deguchi K., Tian F., Shang J., Matsuura T., Abe K., Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion Brain Research 2011 1370 246 253
68. Jin W., Wang H., Yan W., Zhu L., Hu Z., Ding Y., Tang KE., Role of Nrf2 in protection against traumatic brain injury in mice Journal of Neurotrauma 2009 26 1 131 139
69. Shih A. Y., Li P., Murphy T. H., A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo Journal of Neuroscience 2005 25 44 10321 10335 (Pubitemid 41636229)
70. von Otter M., Landgren S., Nilsson S., Zetterberg M., Celojevic D., Bergstrom P., Minthon L., Bogdanovic N., Andreasen N., Gustafson D. R., Skoog I., Wallin A., Tasa G., Blennow K., Nilsson M., Hammarsten O., Zetterberg H., Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract Mechanisms of Ageing and Development 2010 131 2 105 110
71. Ramsey C. P., Glass C. A., Montgomery M. B., Lindl K. A., Ritson G. P., Chia L. A., Hamilton R. L., Chu C. T., Jordan-Sciutto K. L., Expression of Nrf2 in neurodegenerative diseases Journal of Neuropathology and Experimental Neurology 2007 66 1 75 85 (Pubitemid 46066791)
72. Kanninen K., Malm T. M., Jyrkknen H. K., Goldsteins G., Keksa-Goldsteine V., Tanila H., Yamamoto M., Yl-Herttuala S., Levonen A. L., Koistinaho J., Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Molecular and Cellular Neuroscience 2008 39 3 302 313
73. Choudhry F., Howlett D. R., Richardson J. C., Francis P. T., Williams P. T., Pro-oxidant diet enhances beta/gamma secretase-mediated APP processing in APP/PS1 transgenic mice. Neurobiology of Aging. In press
74. Khodagholi F., Eftekharzadeh B., Maghsoudi N., Rezaei P. F., Chitosan prevents oxidative stress-induced amyloid formation and cytotoxicity in NT2 neurons: involvement of transcription factors Nrf2 and NF- B Molecular and Cellular Biochemistry 2010 337 1-2 39 51
75. Ma W., Yuan L., Yu H., Ding B., Xi Y., Feng J., Xiao R., Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by -amyloid peptides 25-35 in PC12 cells International Journal of Developmental Neuroscience 2010 28 4 289 295
76. Wruck C. J., Gotz M. E., Herdegen T., Varoga D., Brandenburg L. O., Pufe T., Kavalactones protect neural cells against amyloid peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation Molecular Pharmacology 2008 73 6 1785 1795 (Pubitemid 351724366)
77. Eftekharzadeh B., Maghsoudi N., Khodagholi F., Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid formation in NT2N neurons Biochimie 2010 92 3 245 253
78. Park H. M., Kim J. A., Kwak M. K., Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome Archives of Pharmacal Research 2009 32 1 109 115
79. Dostal V., Roberts C. M., Link C. D., Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of -amyloid peptide toxicity Genetics 2010 186 3 857 866
80. Kanninen K., Heikkinen R., Malm T., Rolova T., Kuhmonen S., Leinonen H., Yl-Herttuala S., Tanila H., Levonen A. L., Koistinaho M., Koistinaho J., Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2009 106 38 16505 16510
81. Salazar M., Rojo A. I., Velasco D., De Sagarra R. M., Cuadrado A., Glycogen synthase kinase-3 inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2 Journal of Biological Chemistry 2006 281 21 14841 14851 (Pubitemid 43855189)
82. Rojo A. I., Rada P., Egea J., Rosa A. O., Lpez M. G., Cuadrado A., Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal celldeath Molecular and Cellular Neuroscience 2008 39 1 125 132
83. Jain A. K., Jaiswal A. K., Phosphorylation of tyrosine 568 controls nuclear export of Nrf2 Journal of Biological Chemistry 2006 281 17 12132 12142 (Pubitemid 43855477)
84. Jain A. K., Jaiswal A. K., GSK-3 acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2 Journal of Biological Chemistry 2007 282 22 16502 16510 (Pubitemid 47100395)
85. Kay H. Y., Kim Y. W., Lee D. H., Sung S. H., Hwang S. J., Kim S. G., Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCdelta-GSK3beta pathway. British Journal of Pharmacology. In press
86. Espada S., Rojo A. I., Salinas M., Cuadrado A., The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection Journal of Neurochemistry 2009 110 3 1107 1119
87. An J. H., Vranas K., Lucke M., Inoue H., Hisamoto N., Matsumoto K., Blackwell T. K., Regulation of the Caenorhabditis elegans oxidative stress defense protein SKN-1 by glycogen synthase kinase-3 Proceedings of the National Academy of Sciences of the United States of America 2005 102 45 16275 16280 (Pubitemid 41688904)
88. Prestera T., Holtzclaw W. D., Zhang Y., Talalay P., Chemical and molecular regulation of enzymes that detoxify carcinogens Proceedings of the National Academy of Sciences of the United States of America 1993 90 7 2965 2969 (Pubitemid 23113538)
89. Reisinger E. C., Kern P., Ernst M., Bock P., Flad H. D., Dietrich M., Dorlemann A., Schwander S., Berzow D., Schmitz H., Racz P., Gottesleben A., Plettenberg A., Meigel W., Inhibition of HIV progression by dithiocarb Lancet 1990 335 8691 679 682 (Pubitemid 20089306)
90. Liu S. F., Ye X., Malik A. B., Inhibition of NF- B activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes Circulation 1999 100 12 1330 1337 (Pubitemid 29440127)
91. Schreck R., Meier B., Mannel D. N., Droge W., Baeuerle P. A., Dithiocarbamates as potent inhibitors of nuclear factor B activation in intact cells Journal of Experimental Medicine 1992 175 5 1181 1194
92. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., Karin M., Kikugawa K., Evidence that reactive oxygen species do not mediate NF- B activation EMBO Journal 2003 22 13 3356 3366 (Pubitemid 36834865)
93. Verhaegen S., McGowan A. J., Brophy A. R., Fernandes R. S., Cotter T. G., Inhibition of apoptosis by antioxidant in the human HL-60 leukemia cell line Biochemical Pharmacology 1995 50 7 1021 1029
94. Wild A. C., Moinova H. R., Mulcahy R. T., Regulation of -glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2 Journal of Biological Chemistry 1999 274 47 33627 33636 (Pubitemid 129511675)
95. Zipper L. M., Mulcahy R. T., Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells Toxicological Sciences 2003 73 1 124 134 (Pubitemid 36609094)
96. Borrello S., Demple B., NF B-independent transcriptional induction of the human manganous superoxide dismutase gene Archives of Biochemistry and Biophysics 1997 348 2 289 294 (Pubitemid 28028479)
97. Hartsfield C. L., Alam J., Choi A. M. K., Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate FASEB Journal 1998 12 15 1675 1682 (Pubitemid 28553662)
98. Stuhlmeier K. M., Activation and regulation of Hsp32 and Hsp70 European Journal of Biochemistry 2000 267 4 1161 1167 (Pubitemid 30108335)
99. Nobel I., Kimland M., Lind B., Orrenius S., Slater A. F. G., Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper Journal of Biological Chemistry 1995 270 44 26202 26208
100. Liu G.-Y., Frank N., Bartsch H., Lin J.-K., Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NF B, c-fos/c-jun, and p53 proteins Molecular Carcinogenesis 1998 22 4 235 246 (Pubitemid 28394985)
101. Tsai J. C., Jain M., Hsieh C. M., Lee W. S., Yoshizumi M., Patterson C., Perrella M. A., Cooke C., Wang H., Haber E., Schlegel R., Lee MU. E., Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells Journal of Biological Chemistry 1996 271 7 3667 3670 (Pubitemid 26065683)
102. Chinery R., Beauchamp R. D., Shyr Y., Kirkland S. C., Coffey R. J., Morrow J. D., Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells Cancer Research 1998 58 11 2323 2327 (Pubitemid 28252686)
103. Calviello G., Filippi G. M., Toesca A., Palozza P., Maggiano N., Di Nicuolo F., Serini S., Azzena G. B., Galeotti T., Repeated exposure to pyrrolidine-dithiocarbamate induces peripheral nerve alterations in rats Toxicology Letters 2005 158 1 61 71 (Pubitemid 40910728)
104. Chung K. C., Park J. H., Kim C. H., Hyun Woo L., Sato N., Uchiyama Y., Ahn Y. S., Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF- B, and MAP kinases Journal of Neuroscience Research 2000 59 1 117 125 (Pubitemid 30038871)
105. Nurmi A., Goldsteins G., Nrvinen J., Pihlaja R., Ahtoniemi T., Grohn O., Koistinaho J., Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia Free Radical Biology and Medicine 2006 40 10 1776 1784
106. Malm T. M., Iivonen H., Goldsteins G., Keksa-Goldsteine V., Ahtoniemi T., Kanninen K., Salminen A., Auriola S., Van Groen T., Tanila H., Koistinaho J., Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting -amyloid burden Journal of Neuroscience 2007 27 14 3712 3721 (Pubitemid 46557689)
107. Verhaegh G. W., Richard M. J., Hainaut P., Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper Molecular and Cellular Biology 1997 17 10 5699 5706 (Pubitemid 27411077)
108. Bayer T. A., Schfer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schssel K., Eikenberg O., Sturchler-Pierrat C., Abramowski D., Staufenbiel M., Multhaup G., Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid A production in APP23 transgenic mice Proceedings of the National Academy of Sciences of the United States of America 2003 100 24 14187 14192 (Pubitemid 37499212)
109. Maynard C. J., Cappai R., Volitakis I., Cherny R. A., White A. R., Beyreuther K., Masters C. L., Bush A. I., Li Q. X., Overexpression of Alzheimer's disease amyloid- opposes the age-dependent elevations of brain copper and iron Journal of Biological Chemistry 2002 277 47 44670 44676 (Pubitemid 36159056)
110. Phinney A. L., Drisaldi B., Schmidt S. D., Lugowski S., Coronado V., Liang Y., Horne P., Yang J., Sekoulidis J., Coomaraswamy J., Chishti M. A., Cox D. W., Mathews P. M., Nixon R. A., Carlson G. A., St. George-Hyslop P. P., Westaway D., In vivo reduction of amyloid- by a mutant copper transporter Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 14193 14198 (Pubitemid 37499213)
111. Chen S. H., Lin J. K., Liang Y. C., Pan M. H., Liu S. H., Lin-Shiau S. Y., Involvement of activating transcription factors JNK, NF- B, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex European Journal of Pharmacology 2008 594 13 9 17
112. Filiz G., Price K. A., Caragounis A., Du T., Crouch P. J., White A. R., The role of metals in modulating metalloprotease activity in the AD brain European Biophysics Journal 2008 37 3 315 321